Sep 20, 2024 6:27 AM
BACK TO TOP
KSE100
81,459.28
997.95
(1.24%)
ALLSHR
52,009.78
334.77
(0.65%)
KSE30
25,799.85
331.68
(1.30%)
KMI30
129,896.97
1423.49
(1.11%)
BKTI
19,734.58
435.02
(2.25%)
OGTI
20,508.19
151.98
(0.75%)
KMIALLSHR
36,527.25
261.41
(0.72%)
PSXDIV20
33,702.36
426.67
(1.28%)
UPP9
25,125.81
646.47
(2.64%)
NITPGI
19,827.61
428.53
(2.21%)
NBPPGI
21,987.19
473.96
(2.20%)
MZNPI
16,957.96
238.37
(1.43%)
JSMFI
21,307.90
-327.78
(-1.51%)
ACI
12,161.00
82.37
(0.68%)
JSGBKTI
21,479.67
488.95
(2.33%)
MII30
11,921.60
143.05
(1.21%)
HBLTTI
14,932.28
29-08-2024
0.26
(0.00%)
Shifa International Hospitals Limited
MISCELLANEOUS
Rs.169.21
9.48
(5.94%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Thu, Sep 19, 2024 4:03 PM
REG
FUT
ODL
Open
161.00
High
172.90
Low
161.00
Volume
466,328
CIRCUIT BREAKER
143.76 — 175.70
DAY RANGE
161.00 — 172.90
52-WEEK RANGE
109.00 — 173.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
159.73
VAR
22.50
HAIRCUT
27.50
P/E Ratio (TTM) **
7.85
1-Year Change *
44.62%
YTD Change *
20.63%

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Shifa International Hospitals Limited was incorporated in Pakistan on September 29, 1987 as a private limited company under the repealed Companies Ordinance, 1984 and converted into a public limited company on October 12, 1989. The principal activity of the Company is to establish and run medical centers and hospitals in Pakistan. The Company is also running medical centers, pharmacies and Lab collection points in different cities of Pakistan.

KEY PEOPLE
Dr. Zeeshan Bin IshtiaqueCEO
Dr. Habib ur RahmanChairperson
Muhammad NaeemCompany Secretary
ADDRESS

Sector H-8/4, Islamabad, Pakistan

WEBSITE

www.shifa.com.pk

REGISTRAR

M/s Corplink (Private) Limited, Wings Arcade, 1-K, Commercial, Model Town, Lahore

AUDITOR

BDO Ebrahim & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
10,696,505.75
Shares
63,214,383
Free Float
28,446,472
Free Float
45.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Sep 16, 2024Financial Results for the Year Ended 2024-06-30 View   PDF
Apr 30, 2024 Transmission of Quarterly Report for the Period Ended March 31, 2024 View   PDF
Apr 26, 2024Financial Results for the 3rd Quarter Ended 2024-03-31 View   PDF
Mar 1, 2024Transmission of Quarterly Report for the Period Ended 2023-12-31 View   PDF
Feb 29, 2024Transmission of Quarterly Report for the Period Ended 2023-12-31
REVOKED
View   PDF
Feb 26, 2024Financial Results for the 2nd Quarter (Half Year) Ended December 31, 2023 View   PDF
Oct 30, 2023Transmission of Quarterly Report for the Period Ended 2023-09-30 View   PDF
Oct 30, 2023Financial Results for the 1st Quarter Ended 2023-09-30 View   PDF
Oct 6, 2023Transmission of Annual Report for the Year Ended June 30, 2023 View   PDF
Oct 2, 2023Financial Results for the Year Ended 30-06-2023 View   PDF
Apr 28, 2023Transmission of Quarterly Report for the Period Ended March 31, 2023 View   PDF
DateTitleDocument
Sep 4, 2024Board Meeting View   PDF
Jun 24, 2024Board Meeting other than Financial Results View   PDF
Jun 20, 2024Certified Copy of Resollution Adopted in Extraordinary General Meeting of Shifa International Hospitals Ltd held on June 15, 2024 View   PDF
Jun 14, 2024Board Meeting Other Than Financial Results View   PDF
May 27, 2024Notice of Extraordinary General Meeting - Newspaper Clippings View   PDF
May 24, 2024Notice of Extraordinary General Meeting View   PDF
Apr 17, 2024Board Meeting View   PDF
Feb 15, 2024Board Meeting View   PDF
Oct 27, 2023CERTIFIED COPY OF RESOLUTIONS PASSED BY THE SHAREHOLDERS IN THE 37TH ANNUAL GENERAL MEETING View   PDF
Oct 20, 2023Board Meeting View   PDF
DateTitleDocument
Sep 10, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Sep 9, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Sep 5, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Sep 3, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Aug 19, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Aug 16, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Aug 9, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Aug 8, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Aug 5, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Jul 29, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2024202320222021
Sales23,563,84019,721,42516,197,55114,219,718
Profit after Taxation1,362,0741,181,4061,162,549699,924
Q3 2024Q2 2024Q1 2024Q3 2023
Sales5,783,3206,078,4005,941,3865,181,186
Profit after Taxation321,738351,100393,542531,378
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2024202320222021
Gross Profit Margin (%)100.00100.00100.00100.00
Net Profit Margin (%)5.785.997.184.92
EPS Growth (%)15.301.6366.1235.33
PEG0.444.020.150.56

Payouts

DateFinancial ResultsDetailsBook Closure
September 16, 2024 3:51 PM30/06/2024(YR) 25%(F) (D) 18/10/2024 - 28/10/2024
April 26, 2024 3:29 PM31/03/2024(IIIQ) 15%(i) (D) 10/05/2024 - 12/05/2024
October 2, 2023 3:18 PM30/06/2023(YR) 15%(F) (D) 20/10/2023 - 27/10/2023
September 29, 2022 11:28 AM30/06/2022(YR) 15%(F) (D) 21/10/2022 - 28/10/2022
April 28, 2022 12:49 PM31/03/2022(IIIQ) 15% (D) 12/05/2022 - 14/05/2022
September 27, 2021 12:37 PM30/06/2021(YR) 2% (B) 21/10/2021 - 28/10/2021
September 16, 2019 2:13 PM30/06/2019(YR) 25.5% (F) (D) 19/10/2019 - 26/10/2019
September 10, 2018 9:50 AM30/06/2018(YR) 45% (D) 18/10/2018 - 27/10/2018
September 12, 2017 9:54 AM30/06/2017(YR) 50% (D) 18/10/2017 - 27/10/2017
August 25, 2016 3:21 PM30/06/2016(YR) 30% (D) 22/10/2016 - 29/10/2016

Financial Reports